CI
DGX icon

Cambiar Investors’s Quest Diagnostics DGX Stock Holding History

Cambiar Investors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Sell
17,090
-1,585
-8% -$311K 0.16% 78
2026
Q1 		$3.66M Sell
18,675
-5,055
-21% -$982K 0.17% 76
2025
Q4 		$4.12M Sell
23,730
-3,668
-13% -$668K 0.18% 80
2025
Q3 		$5.22M Sell
27,398
-19,433
-41% -$3.45M 0.24% 70
2025
Q2 		$8.41M Sell
46,831
-21,899
-32% -$3.8M 0.35% 74
2025
Q1 		$11.6M Sell
68,730
-10,653
-13% -$1.75M 0.49% 54
2024
Q4 		$12M Sell
79,383
-9,196
-10% -$1.43M 0.47% 55
2024
Q3 		$13.8M Sell
88,579
-4,770
-5% -$712K 0.53% 54
2024
Q2 		$12.8M Sell
93,349
-884
-0.9% -$121K 0.5% 56
2024
Q1 		$12.5M Buy
94,233
+15,059
+19% +$1.95M 0.47% 69
2023
Q4 		$10.9M Buy
79,174
+3,561
+5% +$468K 0.43% 82
2023
Q3 		$9.21M Buy
75,613
+200
+0.3% +$26.6K 0.39% 83
2023
Q2 		$10.6M Buy
75,413
+6,425
+9% +$886K 0.45% 71
2023
Q1 		$9.76M Buy
68,988
+11,848
+21% +$1.7M 0.42% 72
2022
Q4 		$8.94M Sell
57,140
-8,506
-13% -$1.22M 0.41% 66
2022
Q3 		$8.05M Sell
65,646
-697
-1% -$91.8K 0.41% 63
2022
Q2 		$8.82M Buy
+66,343
New +$9.04M 0.39% 65

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cambiar Investors's DGX Position: Q2 2026 in Review

Cambiar Investors reduced its Quest Diagnostics (DGX) stake by 8.5% in Q2 2026, selling an estimated $311K and leaving 17,090 shares worth $3.62M. The position accounts for 0.16% of the portfolio, ranked #78.

Cambiar Investors first reported a position in DGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $13.8M in Q3 2024. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cambiar Investors held 17,090 shares of Quest Diagnostics worth $3.62M as of Q2 2026.
  • Cambiar Investors sold 1,585 Quest Diagnostics shares in Q2 2026, an estimated $311K.
  • Quest Diagnostics made up 0.16% of Cambiar Investors's portfolio in Q2 2026, its #78 holding.
  • Cambiar Investors first reported a position in Quest Diagnostics in Q2 2022 and has held it in 17 quarters since.
  • Cambiar Investors's Quest Diagnostics position peaked at $13.8M in Q3 2024.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.